Publications by authors named "Naveen Basappa"

Claim this Profile
I
Incidence of Local Treatment and Metastasis During Active Surveillance for Patients With a Small Renal Mass in a National Multicenter Prospective Cohort.
Luke T Lavallée, Antonio Finelli, Simon Tanguay, Bimal Bhindi, Lori A Wood, Naveen Basappa

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Luke T Lavallée, Antonio Finelli, Simon Tanguay, Bimal Bhindi, Lori A Wood, Naveen Basappa

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Luke T Lavallée, Antonio Finelli, Simon Tanguay, Bimal Bhindi, Lori A Wood, Naveen Basappa

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Luke T Lavallée, Antonio Finelli, Simon Tanguay, Bimal Bhindi, Lori A Wood, Naveen Basappa

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.
Manon De Vries-Brilland, Zineb Hamilou, Sunita Ghosh, Daniel Y C Heng, Lori A Wood, Naveen S Basappa

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study.
Ghady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, Christian Kollmannsberger, Naveen S Basappa

Clin Genitourin Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?
Mustafa Soytas, Alice Dragomir, Ghady Bou-Nehme Sawaya, Charles Hesswani, Maude Tanguay, Naveen S Basappa

BJU Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortality.
Anita Robert, Ranjeeta Mallick, Daniel I McIsaac, Luke T Lavallée, Bimal Bhindi, Naveen Basappa

J Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis.
Mehul Gupta, Connor Wells, Meredith M Regan, Wanling Xie, Vishal Navani, Naveen S Basappa

Eur Urol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients.
Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, Camilla Tajzler, Lori A Wood, Naveen S Basappa

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
Geoffrey T Gotto, Steven M Yip, Bobby Shayegan, Dylan E O'Sullivan, Christopher J D Wallis, Naveen S Basappa

Can Urol Assoc J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Kosuke Takemura, Audreylie Lemelin, Matthew S Ernst, J Connor Wells, Renee Maria Saliby, Naveen S Basappa

Eur Urol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.
Jeffrey Graham, Ardalan E Ahmad, Naveen S Basappa, Jean-Christophe Bernhard, Bimal Bhindi

Can Urol Assoc J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Eddy Saad, Georges Gebrael, Karl Semaan, Marc Eid, Renée Maria Saliby, Naveen S Basappa

Oncologist· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.
Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh, Lori Wood, Georg A Bjarnason, Naveen S Basappa

Curr Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Troponin T in Immune-Checkpoint Inhibitor Myositis: A Case of Mistaken Myocarditis.
Carissa Beaulieu, Kai Yi Wu, Anna K Füzéry, Joshua E Raizman, Albert K Y Tsui, Naveen S Basappa

JACC Case Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of First Subsequent Taxane Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Who Previously Received Docetaxel Intensification for Metastatic Castration-Sensitive Prostate Cancer.
Gabrielle Robin, Naveen S Basappa, Scott North, Sunita Ghosh, Michael Kolinsky

Curr Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study.
Robert J Motzer, Toni K Choueiri, Thomas Hutson, Sun Young Rha, Javier Puente, Naveen S Basappa

Eur Urol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Kosuke Takemura, Matthew S Ernst, Vishal Navani, J Connor Wells, Ziad Bakouny, Naveen S Basappa

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Ghady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, Christian Kollmannsberger, Naveen S Basappa

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial.
James Chih-Hsin Yang, Baohui Han, Emmanuel De La Mora Jiménez, Jong-Seok Lee, Piotr Koralewski, Naveen S Basappa

J Thorac Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis).
Jeffrey Graham, Sunita Ghosh, Rodney H Breau, Lori Wood, Simon Tanguay, Naveen S Basappa

Clin Genitourin Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing controversial areas in the management of advanced prostate cancer in Canada Areas of consensus and controversy from the third Canadian consensus forum.
Fred Saad, Sebastien J Hotte, Krista Noonan, Shawn Malone, Christopher Morash, Naveen S Basappa

Can Urol Assoc J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience.
Hanbo Zhang, Nimira S Alimohamed, Naveen S Basappa, Tina Cheng, Michael Chu

Can Urol Assoc J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System.
Luisa M Cardenas, Sunita Ghosh, Antonio Finelli, Lori Wood, Christian Kollmannsberger, Naveen Basappa

JCO Glob Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis